ExThera Medical Overview

  • Founded
  • 2007

Founded
  • Status
  • Private

  • Employees
  • 27

Employees
  • Latest Deal Type
  • Series B3

  • Latest Deal Amount
  • $6.71M

  • Investors
  • 5

ExThera Medical General Information

Description

Developer of extracorporeal blood filtration devices designed to offer treatment of bloodstream infections. The company's medical devices include a single-use blood filter capable of capturing and removing a broad range of bacteria, viruses, parasites, toxins and other harmful substances from whole blood, enabling clinics and healthcare organizations to address unmet clinical needs of pathogen reduction in blood banking.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
  • 757 Arnold Drive
  • Suite B
  • Martinez, CA 94553
  • United States
+1 (925) 000-0000

ExThera Medical Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ExThera Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B3) 10-Sep-2021 $6.71M 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series B1) 17-Mar-2021 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 11-May-2016 000.00 000.00 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 11-May-2016 $12M $12M 000.00 Completed Generating Revenue
1. Joint Venture 01-Jan-2007 Completed Startup
To view ExThera Medical’s complete valuation and funding history, request access »

ExThera Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-3 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series B-2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B-1 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series B 9,491,945 $0.001000 $0.15 $1.82 $1.82 1x $1.82 13.74%
Series A 12,008,982 $0.001000 $0.08 $1 $1 1x $1 17.38%
To view ExThera Medical’s complete cap table history, request access »

ExThera Medical Patents

ExThera Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3137294-A1 Method for modulating endothelial glycocalyx structure Pending 16-May-2019 0000000000
US-10786615-B2 Method for treating drug intoxication Active 02-Mar-2016 0000000000 00
US-20170252502-A1 Method for treating drug intoxication Granted 02-Mar-2016 0000000000
US-20210008269-A1 Method for treating drug intoxication Pending 02-Mar-2016 000000000
EP-3422943-A4 Method for treating drug intoxication Pending 02-Mar-2016 A61M1/3621
To view ExThera Medical’s complete patent history, request access »

ExThera Medical Executive Team (7)

Name Title Board Seat Contact Info
Robert Ward Ph.D Chief Executive Officer, Chairman & President
Keith McCrea Ph.D Chief Science Officer, Vice President of Research and Developement & Board Member
Samuel Shull Chief Commercial Officer
You’re viewing 3 of 7 executive team members. Get the full list »

ExThera Medical Board Members (8)

Name Representing Role Since
Eber Jaques Self Board Member 000 0000
Erin Borger ExThera Medical Board Member 000 0000
Gregory Dollarhyde Self Board Member 000 0000
John Feik Self Board Member 000 0000
John Preston Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

ExThera Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ExThera Medical Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cycad Group Venture Capital Minority 000 0000 000000 0
NaHCO3 Impact Investing Minority 000 0000 000000 0
Fresenius Medical Care Ventures Corporate Venture Capital Minority 000 0000 000000 0
Emergence Venture Partners Venture Capital Majority 000 0000 000000 0
ExThera AB Corporation Majority 000 0000 000000 0
To view ExThera Medical’s complete investors history, request access »